CANNAINVESTOR Magazine March / April 2017 - Page 179

Medmen - IMN Conference a huge success

MedMen, an industry leading cannabis management services company and investment firm, and IMN, a premier finance and investment conference organizer have been hosting the Institutional Capital & Cannabis Conference at the Hayes Mansion in San Jose, California and the turnout was impressive. I was hosting a booth and interviewing numerous attendees.

In anticipation of further legalization, MedMen and IMN created this inaugural event which is focusing on the legal cannabis business as an alternative asset class to achieve portfolio diversification. This event was created specifically with the needs of the institutional and accredited investor in mind.

In Tuesday's session we heard from Adam Bierman, Co-Founder and CEO of Medmen, Roy Binghma, CEO of BDS Analytics, Vivien Azer, Managing Director of Cowen and Company, Jeffrey Friedland, Managing Director of Friedland Capital and Matt Karnes from Greenwave Advisors (both of whom I hosted on my weekly Wall Street Raw radio program). Other speakers included Primm Fox from Bloomberg Radio, and Steve Kaplan, Head of Capital Markets from Ladenburg Thalmann, the firm that recent took Innovative Industrial Properties, the Cannabis REIT, public.

Aurora Cannabis to Take 19.9% Stake in Australia’s Cann Group IPO

Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) announced that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor, securing a 19.9% stake in Cann Group, the first company in Australia ever to be licenced for research and cultivation of medical cannabis for human use.

The joint lead manager and underwriters to the offer are Canaccord Genuity (Australia) Limited and PAC Partners Pty Ltd. Under the terms of the subscription agreement Aurora has committed to subscribe for 21,562,314 ‘new fully paid ordinary shares’ in Cann Group at the IPO offer price per share of AUD $0.30. Aurora’s total investment of AUD $6.5M (approximately CAD $6.6M) represents 47% of the AUD $13.5M offer.